Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NKTR

Nektar Therapeutics

May 22 • 04:00PM ET

66.61

-1.97 -2.87 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: JANX ARVN XNCR IOVA ALLO

| Held by: VTI VXF SCHA VHT XPH IHE PRFZ LFSC DWAS ITOT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-8.42	Insider Own	3.53%	Shs Outstand	33.79M	Perf Week	-5.68%
Market Cap	2.25B	Forward P/E	-	EPS next Y	-11.07	Insider Trans	-0.43%	Shs Float	32.59M	Perf Month	-27.01%
Enterprise Value	1.83B	PEG	-	EPS next Q	-2.04	Inst Own	76.67%	Short Float	12.59%	Perf Quarter	-9.52%
Income	-158.10M	P/S	40.45	EPS this Y	6.87%	Inst Trans	27.29%	Short Ratio	4.04	Perf Half Y	10.37%
Sales	55.63M	P/B	2.36	EPS next Y	-22.20%	ROA	-31.01%	Short Interest	4.10M	Perf YTD	57.54%
Book/sh	28.28	P/C	3.96	EPS next 5Y	-5.42%	ROE	-53.60%	52W High	109.00 -38.89%	Perf Year	572.83%
Cash/sh	16.83	P/FCF	-	EPS past 3/5Y	30.93% 23.59%	ROIC	-22.68%	52W Low	7.99 733.67%	Perf 3Y	509.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-15.66% -18.43%	Gross Margin	98.65%	Volatility	4.43% 4.81%	Perf 5Y	-75.36%
Dividend TTM	-	EV/Sales	32.81	EPS Y/Y TTM	11.52%	Oper. Margin	-224.08%	ATR (14)	4.07	Perf 10Y	-67.91%
Dividend Ex-Date	-	Quick Ratio	10.21	Sales Y/Y TTM	-36.24%	Profit Margin	-284.18%	RSI (14)	30.96	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	10.21	EPS Q/Q	49.83%	SMA20	-14.90%	Beta	-0.84	Target Price	153.25
Payout	-	Debt/Eq	0.25	Sales Q/Q	3.83%	SMA50	-15.14%	Rel Volume	0.52	Prev Close	68.58
Employees	63	LT Debt/Eq	0.21	Earnings	May 07 AMC	SMA200	15.47%	Avg Volume	1.01M	Price	66.61
IPO	May 03, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.02% 1.59%	Trades		Volume	547,882	Change	-2.87%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)